http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101055376-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2015-8527 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0275 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 |
| filingDate | 2008-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101055376-B1 |
| titleOfInvention | CIIA transgenic mice resistant to degenerative neurological disease |
| abstract | The present invention relates to a transgenic animal overexpressing a CIIA protein and a method for producing the transgenic animal. Transgenic mice expressing CIIA of the present invention are remarkably excellent in resistance to neuronal cell death, and thus may be widely used as animal models for the development of therapeutic agents for neurodegenerative diseases.n n n n CIIA, transgenic mouse, Amyotrophic Lateral Sclerosis (ALS), ischemia |
| priorityDate | 2008-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 338.